Clinical Trials Logo

Clinical Trial Summary

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.


Clinical Trial Description

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce ICU and hospital length of stay. ;


Study Design


Related Conditions & MeSH terms

  • Post-operative Pulmonary Complications

NCT number NCT03024112
Study type Interventional
Source University of Colorado, Denver
Contact
Status Completed
Phase N/A
Start date August 2013
Completion date June 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05526534 - A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms N/A